IBX Insider Trading (Imagion Biosystems)
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$3,750.00
Insider Selling (Last 12 Months): A$0.00
Imagion Biosystems Share Price & Price History
Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET
High Arch Potential Stock
If you're looking for a hot new sector, watch this stock closely.
Click for ticker & full details
Imagion Biosystems Insider Trading History
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|11/10/2021||Mark Van Asten||Insider||Buy||75,000||A$0.05||A$3,750.00|
|6/24/2019||Michael (Mike) Harsh||Insider||Exercise||150,000||A$0.02||A$2,550.00|
140 Pounds of Lithium in One Tesla Adds Up Quickly
Each 70 kWh Tesla Model S battery pack contains nearly 140 pounds of lithium, the energy metal. The megatrend of electrifying vehicles will only add to lithium demand, expected to skyrocket 1,000% or more by 2030.
See Who Will Benefit From This Lithium Opportunity
SEC Filings (Institutional Ownership Changes) for Imagion Biosystems (ASX:IBX)
Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis; and a joint development agreement with Global Cancer Technology, Inc. to develop GCT's novel nanoscintillator technology for the treatment of breast cancer. The company was incorporated in 2016 and is based in San Diego, California.
50 Day Range
52 Week Range
Who are the company insiders with the largest holdings of Imagion Biosystems?